Overexpression of PD-associated α-synuclein mutants also increased α-synuclein levels to the same extent as WT α-synuclein, suggesting that USP10 inhibits the degradation of WT and mutant α-synuclein with similar efficiency (Fig. 7, F and G). Here, USP10 is linked to Parkinson disease.